Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00202033 · ClinicalTrials.gov registry record · Phase 4
Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
A Phase 4 study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT00202033 is a Phase 4 study that has completed, run by HealthPartners Institute. The registered enrollment target is 150 participants.
The verdict
NCT00202033, a Phase 4 study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
To determine if the frequency of blood glucose testing in patients with type 2 diabetes who are being treated with diet and exercise alone or diet and exercise plus oral agents will impact the HbA1c level.
Interventions
- BEHAVIORAL frequency of self monitoring blood glucose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00202033
The ClinicalTrials.gov registry entry for NCT00202033 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which frequency of self monitoring blood glucose is the first listed.
NCT00202033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00202033 about?
NCT00202033 is a clinical study titled "Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes". To determine if the frequency of blood glucose testing in patients with type 2 diabetes who are being treated with diet and exercise alone or diet and exercise plus oral agents will impact the HbA1c level.
What is the current status of trial NCT00202033?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2004-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00202033?
The interventions under investigation include: frequency of self monitoring blood glucose (BEHAVIORAL).
Who is sponsoring clinical trial NCT00202033?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.